FACTANKER · measured, cited, anchored official records connected
FACTANKERSearch ↗

Titan Pharmaceuticals, Inc. — Revenue by Fiscal Year

15 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/338b1906-7499-4f87-92d3-e2bf8726c2f6/serie/revenue

Fiscal yearRevenuePeriodEvidence
FY 2023$184.0k2023-01-01 – 2023-12-31evidence 0001829126-24-002110
FY 2022$557.0k2022-01-01 – 2022-12-31evidence 0001829126-23-002504
FY 2021$1.5M2021-01-01 – 2021-12-31evidence 0001410578-22-000518
FY 2020$4.8M2020-01-01 – 2020-12-31evidence 0001104659-21-044732
FY 2019$2.6M2019-01-01 – 2019-12-31evidence 0001104659-21-044732
FY 2018$6.6M2018-01-01 – 2018-12-31evidence 0001144204-19-017459
FY 2017$02017-01-01 – 2017-12-31evidence 0001144204-19-017459
FY 2016$02016-01-01 – 2016-12-31evidence 0001144204-19-017459
FY 2015$1.7M2015-01-01 – 2015-12-31evidence 0001144204-16-088046
FY 2014$3.6M2014-01-01 – 2014-12-31evidence 0001144204-15-019881
FY 2013$10.5M2013-01-01 – 2013-12-31evidence 0001144204-14-019329
FY 2012$7.1M2012-01-01 – 2012-12-31evidence 0001193125-13-111045
FY 2011$4.1M2011-01-01 – 2011-12-31evidence 0001193125-12-117326
FY 2010$10.1M2010-01-01 – 2010-12-31evidence 0001193125-12-117326
FY 2009$79.0k2009-01-01 – 2009-12-31evidence 0001193125-12-117326
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

Titan Pharmaceuticals, Inc. — all facts · Net Income · Operating Income